
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
Table of Contents
over 23 years ago
One World, Many Regulationsover 23 years ago
Membership Has Its Privilegesover 23 years ago
The Right Staffover 23 years ago
The Virtues of Virtual Trainingover 23 years ago
Executive Prophesies Vision for the Future





